Table 1. Correlation of IQCJ-SCHIP1-AS1 expression with clinicopathologic features in CRC.
| Characteristics | n | Low expression (%) | High expression (%) | χ2 | P value |
|---|---|---|---|---|---|
| Ages (years) | 0.977 | 0.323 | |||
| ≥60 | 50 | 29 (58.0) | 21 (42.0) | ||
| <60 | 36 | 17 (47.2) | 19 (52.8) | ||
| Gender | 0.698 | 0.403 | |||
| Female | 45 | 26 (57.8) | 19 (42.2) | ||
| Male | 41 | 20 (48.8) | 21 (51.2) | ||
| Tumor size (cm) | 0.197 | 0.264 | |||
| ≥5 | 54 | 26 (48.1) | 28 (51.9) | ||
| <5 | 32 | 20 (62.5) | 12 (37.5) | ||
| Location | 1.485 | 0.223 | |||
| Rectum | 37 | 17 (45.9) | 20 (54.1) | ||
| Colon | 49 | 29 (59.2) | 20 (40.8) | ||
| Differentiation | 4.993 | 0.025 | |||
| Poorly | 74 | 36 (48.6) | 38 (51.4) | ||
| Well+ moderately | 12 | 10 (83.3) | 2 (16.7) | ||
| Depth of tumor | 5.254 | 0.022 | |||
| T3 + T4 | 15 | 4 (26.7) | 11 (73.3) | ||
| T1 + T2 | 71 | 42 (59.2) | 29 (40.8) | ||
| Lymphatic invasion | 6.589 | 0.010 | |||
| Yes | 41 | 16 (39.0) | 25 (61.0) | ||
| No | 45 | 30 (66.7) | 15 (33.3) | ||
| Tumor stage | 7.684 | 0.006 | |||
| III + IV | 40 | 15 (37.5) | 25 (62.5) | ||
| I + II | 46 | 31 (67.4) | 15 (32.6) |
IQCJ-SCHIP1-AS1, IQCJ-SCHIP1 antisense RNA 1; CRC, colorectal cancer.